Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes
Lancet Diabetes Endocrinol
.
2022 Dec;10(12):840.
doi: 10.1016/S2213-8587(22)00312-6.
Authors
Sverre E Kjeldsen
1
,
Mattias Brunström
2
,
Costas Thomopoulos
3
,
Bo Carlberg
2
,
Reinhold Kreutz
4
,
Giuseppe Mancia
5
Affiliations
1
University of Oslo, Faculty of Medicine, Department of Cardiology, Ullevaal Hospital, N-0407 Oslo, Norway. Electronic address:
[email protected]
.
2
Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
3
Department of Cardiology, Helena Venizelou Hospital, Athens, Greece.
4
Charité - Charité - Universitätsmedizin Berlin, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany.
5
University of Milano-Bicocca, Milan, Italy.
PMID:
36427519
DOI:
10.1016/S2213-8587(22)00312-6
No abstract available
Publication types
Letter
Comment
MeSH terms
Blood Pressure
Cardiovascular Diseases* / epidemiology
Diabetes Mellitus, Type 2* / complications
Humans
Risk Factors